EMCURE
Invest with MTF
Invest Now
Invest in Emcure Pharmaceuticals with 3.28X leverage
Performance
- Low
- ₹1,467
- High
- ₹1,550
- 52 Week Low
- ₹889
- 52 Week High
- ₹1,586
- Open Price₹1,550
- Previous Close₹1,535
- Volume210,425
- 50 DMA₹1,461.39
- 100 DMA₹1,421.99
- 200 DMA₹1,382.57
Investment Returns
- Over 1 Month + 3.59%
- Over 3 Month + 11.9%
- Over 6 Month + 5.06%
- Over 1 Year + 18.18%
Smart Investing Starts Here Start SIP with Emcure Pharmaceuticals for Steady Growth!
Emcure Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 32.3
- PEG Ratio
- 0.7
- Market Cap Cr
- 28,100
- P/B Ratio
- 5.9
- Average True Range
- 59.66
- EPS
- 47.73
- Dividend Yield
- 0.2
- MACD Signal
- 14.42
- RSI
- 49.5
- MFI
- 61.81
Emcure Pharmaceuticals Financials
Emcure Pharmaceuticals Technicals
EMA & SMA
Current Price
₹1,482.30
-52.6
(-3.43%)
- Bearish Moving Average 9
- Bullish Moving Average 7
- 20 Day
- ₹1,492.34
- 50 Day
- ₹1,461.39
- 100 Day
- ₹1,421.99
- 200 Day
- ₹1,382.57
Resistance and Support
1499.7
- R3 1,615.80
- R2 1,582.90
- R1 1,532.60
- S1 1,449.40
- S2 1,416.50
- S3 1,366.20
Emcure Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Emcure Pharmaceuticals F&O
About Emcure Pharmaceuticals
- NSE Symbol
- EMCURE
- BSE Symbol
- 544210
- Managing Director & CEO
- Mr. Satish Ramanlal Mehta
- ISIN
- INE168P01015
Similar Stocks to Emcure Pharmaceuticals
Emcure Pharmaceuticals FAQs
Emcure Pharmaceuticals share price is ₹1,482 As on 06 February, 2026 | 04:51
The Market Cap of Emcure Pharmaceuticals is ₹28100.3 Cr As on 06 February, 2026 | 04:51
The P/E ratio of Emcure Pharmaceuticals is 32.3 As on 06 February, 2026 | 04:51
The PB ratio of Emcure Pharmaceuticals is 5.9 As on 06 February, 2026 | 04:51
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.